Latest news
Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Fri, 07 Aug 2026 17:17:14 GMTNew molecular glue platform broadens E3 ligase targeting for cancer drug development - Drug Target ReviewDrug Target Review · Fri, 07 Aug 2026 14:19:12 GMTDana-Farber team develops degrader platform, discovers first metabolically activated molecular glue - Bioengineer.orgBioengineer.org · Thu, 06 Aug 2026 21:18:49 GMTFirst metabolically activated molecular glue degrader may target cancer cells under oxidative stress - Phys.orgPhys.org · Thu, 06 Aug 2026 18:20:04 GMTDCAF11-dependent molecular glue degrader activated by glutathionylation - NatureNature · Wed, 05 Aug 2026 15:30:06 GMTUbiquitin family as novel protein partners for molecular glues - NatureNature · Tue, 04 Aug 2026 06:39:21 GMTIsoprene Pharmaceuticals secures $1.02M NCI grant for prostate cancer degrader IND-enabling studies - AllSciAllSci · Mon, 27 Jul 2026 14:43:34 GMT